Skip to main content

2 Result(s)

within Mengzhou Guo Remove this filter

and

  1. Article

    Open Access

    Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis

    Fibrinogen-like protein 1 (FGL1)—Lymphocyte activating gene 3 (LAG-3) pathway is a promising immunotherapeutic target and has synergistic effect with programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1)...

    Mengzhou Guo, Feifei Yuan, Feng Qi, Jialei Sun… in Journal of Translational Medicine (2020)

    Download PDF (2242 KB) View Article

  2. No Access

    Article

    Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma

    Platinum–fluoropyrimidine combinations are the preferred first-line options for advanced gastric cancer (AGC) in East Asia. On the other hand, docetaxel-containing regimens without platinum have demonstrated p...

    Mengzhou Guo, Yiyi Yu, Yan Wang, Yuehong Cui, Qian Li, Yi Feng, Wei Li… in Medical Oncology (2015)